- Home
- PRZO vs POAI Comparison
PRZO vs POAI Comparison
Compare PRZO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- POAI
- Stock Information
- Founded
- PRZO 2014
- POAI 2002
- Country
- PRZO Israel
- POAI United States
- Employees
- PRZO N/A
- POAI N/A
- Industry
- PRZO
- POAI Industrial Specialties
- Sector
- PRZO
- POAI Health Care
- Exchange
- PRZO Nasdaq
- POAI Nasdaq
- Market Cap
- PRZO 25.7M
- POAI 7.8M
- IPO Year
- PRZO 2023
- POAI N/A
- Fundamental
- Price
- PRZO $1.46
- POAI $0.93
- Analyst Decision
- PRZO
- POAI Hold
- Analyst Count
- PRZO 0
- POAI 1
- Target Price
- PRZO N/A
- POAI N/A
- AVG Volume (30 Days)
- PRZO 887.0K
- POAI 122.8K
- Earning Date
- PRZO 08-28-2025
- POAI 11-11-2025
- Dividend Yield
- PRZO N/A
- POAI N/A
- EPS Growth
- PRZO N/A
- POAI N/A
- EPS
- PRZO N/A
- POAI N/A
- Revenue
- PRZO $1,007,440.00
- POAI $1,664,696.00
- Revenue This Year
- PRZO N/A
- POAI $486.27
- Revenue Next Year
- PRZO N/A
- POAI $65.50
- P/E Ratio
- PRZO N/A
- POAI N/A
- Revenue Growth
- PRZO 80.42
- POAI 71.65
- 52 Week Low
- PRZO $0.53
- POAI $0.55
- 52 Week High
- PRZO $3.16
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- PRZO 52.41
- POAI 55.05
- Support Level
- PRZO $1.25
- POAI $0.90
- Resistance Level
- PRZO $1.37
- POAI $1.08
- Average True Range (ATR)
- PRZO 0.09
- POAI 0.07
- MACD
- PRZO 0.02
- POAI 0.00
- Stochastic Oscillator
- PRZO 63.64
- POAI 36.09
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.